Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology-Reference-Cited by-同舟云学术

Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology

Published:2023-02 Issue: Volume:148 Page:107137
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Patti Giuseppe,Cavallari Ilaria,Cesaro Arturo,Gragnano Felice,Riva Letizia,Fimiani Fabio,Cuccia Claudio,Fresco Claudio,Calabrò Paolo,Leonardi Sergio,Marcucci Rossella,Rubboli Andrea

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference73 articles.

1. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis;Skålén;Nature.,2002

2. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries;Schwenke;Arteriosclerosis,2022

3. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications;Tabas;Circulation.,2007

4. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel;Ference;Eur. Heart J.,2017

5. Global epidemiology of dyslipidaemias;Pirillo;Nat. Rev. Cardiol.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Anti-PCSK9 Antibodies: Real-World Data;Journal of Clinical Medicine;2024-08-03

2. Comprehensive review of statin-intolerance and the practical application of Bempedoic Acid;Journal of Cardiology;2024-07

3. Multi-omics analysis reveals the mechanism of Lacticaseibacillus paracasei IMAUJBC1 in alleviating hyperlipidemia;Journal of Functional Foods;2024-03

4. Beyond statins: New pharmacological targets to decrease LDL-cholesterol and cardiovascular events;Pharmacology & Therapeutics;2023-10